Chen Yi-Chun, Wu Hsiu-Mei, Chen Shih-Jen, Lee Han-Jui, Lirng Jiing-Feng, Lin Chung-Jung, Chang Feng-Chi, Luo Chao-Bao, Guo Wan-Yuo
Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.
National Yang Ming University, School of Medicine, Taipei, Taiwan.
Facial Plast Surg. 2018 Jun;34(3):325-329. doi: 10.1055/s-0037-1621730. Epub 2018 Jan 29.
Cosmetic facial filler-related central retinal artery occlusion (CRAO) is a devastating complication of facial hyaluronic acid (HA) injection and can be managed by intra-arterial thrombolytic therapy (IATT). The authors report on a 20-year-old woman who developed unilateral CRAO due to facial HA injection and who, despite prompt IATT, lost vision. A review of the related literature found 14 other female patients who developed cosmetic facial filler-related CRAO and accepted IATT management. In no case was vision loss clinically improved. IATT is not an effective preventive treatment of dermal filler-associated CRAO. The authors suggest careful preprocedural patient selection to prevent this complication.
与美容面部填充剂相关的视网膜中央动脉阻塞（CRAO）是面部透明质酸（HA）注射的一种毁灭性并发症，可通过动脉内溶栓治疗（IATT）进行处理。作者报告了一名20岁女性，因面部HA注射导致单侧CRAO，尽管及时进行了IATT治疗，但仍失去了视力。对相关文献的回顾发现，另有14名女性患者发生了与美容面部填充剂相关的CRAO并接受了IATT治疗。在任何情况下，视力丧失在临床上均未得到改善。IATT并非治疗与真皮填充剂相关的CRAO的有效预防性治疗方法。作者建议在术前仔细选择患者以预防这种并发症。
